Literature DB >> 23685050

Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.

Rebecca M Tucker1, Amy G Feldman, Erika K Fenner, Cara L Mack.   

Abstract

BACKGROUND & AIMS: Biliary atresia (BA) is a pediatric inflammatory disease of the biliary system which leads to cirrhosis and the need for liver transplantation. One theory regarding etiology is that bile duct injury is due to virus-induced autoreactive T cell-mediated inflammation. Regulatory T cell (Treg) abnormalities in BA could result in unchecked bystander inflammation and autoimmunity targeting bile ducts. The aim of this study was to determine if Tregs are dysfunctional in the rotavirus-induced mouse model of BA (murine BA).
METHODS: Murine BA resulted from infection of BALB/c neonates with Rhesus rotavirus (RRV).
RESULTS: Liver Tregs from BA mice were decreased in number, activation marker expression, and suppressive function. Adoptive transfer studies revealed that RRV-infected mice that received Tregs had significantly increased survival (84%) compared to controls (12.5%). In addition, ablation of Tregs in older mice, followed by RRV infection, resulted in increased bile duct injury.
CONCLUSIONS: These studies demonstrate that dysregulation of Tregs is present in murine BA and that diminished Treg function may be implicated in the pathogenesis of human BA. Published by Elsevier B.V.

Entities:  

Keywords:  APCs; BA; Biliary atresia; Murine autoimmunity; RRV; Regulatory T cells; Rhesus rotavirus; Tregs; antigen presenting cells.; biliary atresia; regulatory T cells

Mesh:

Year:  2013        PMID: 23685050      PMCID: PMC3855478          DOI: 10.1016/j.jhep.2013.05.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  46 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

2.  Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia.

Authors:  Barrett H Barnes; Rebecca M Tucker; Fabian Wehrmann; Doug G Mack; Yoshiyuki Ueno; Cara L Mack
Journal:  Liver Int       Date:  2008-11-15       Impact factor: 5.828

3.  Decreased frequencies of CD4+CD25+Foxp3+ cells and the potent CD103+ subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice.

Authors:  Colleen F Tucker; Doreen L Nebane-Ambe; Anita Chhabra; Sarah A Parnell; Yuan Zhao; Pascale Alard; Michele M Kosiewicz
Journal:  Autoimmunity       Date:  2011-05-23       Impact factor: 2.815

4.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

5.  α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia.

Authors:  Brandy R Lu; Stephen M Brindley; Rebecca M Tucker; Cherie L Lambert; Cara L Mack
Journal:  Gastroenterology       Date:  2010-07-23       Impact factor: 22.682

6.  Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE.

Authors:  Sandra Gültner; Tanja Kuhlmann; Amke Hesse; Jan P Weber; Constanze Riemer; Michael Baier; Andreas Hutloff
Journal:  Eur J Immunol       Date:  2010-11-11       Impact factor: 5.532

7.  Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice.

Authors:  Jeong Kim; Katharina Lahl; Shohei Hori; Christoph Loddenkemper; Ashutosh Chaudhry; Paul deRoos; Alexander Rudensky; Tim Sparwasser
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.

Authors:  Paul L Bollyky; Ben A Falk; S Alice Long; Anton Preisinger; Kathy R Braun; Rebecca P Wu; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

9.  Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia.

Authors:  Celine S Lages; Julia Simmons; Claire A Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2012-06-06       Impact factor: 17.425

Review 10.  Role of IL-17 and Th17 cells in liver diseases.

Authors:  Linda Hammerich; Felix Heymann; Frank Tacke
Journal:  Clin Dev Immunol       Date:  2010-12-15
View more
  22 in total

1.  Identification of a plant isoflavonoid that causes biliary atresia.

Authors:  Kristin Lorent; Weilong Gong; Kyung A Koo; Orith Waisbourd-Zinman; Sara Karjoo; Xiao Zhao; Ian Sealy; Ross N Kettleborough; Derek L Stemple; Peter A Windsor; Stephen J Whittaker; John R Porter; Rebecca G Wells; Michael Pack
Journal:  Sci Transl Med       Date:  2015-05-06       Impact factor: 17.956

Review 2.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

3.  A wave of Foxp3+ regulatory T cell accumulation in the neonatal liver plays unique roles in maintaining self-tolerance.

Authors:  Mingyang Li; Weijia Zhao; Yifan Wang; Lixue Jin; Gaowen Jin; Xiuyuan Sun; Wei Wang; Ke Wang; Xi Xu; Jie Hao; Rong Jin; Wenxian Fu; Ying Sun; Yingjun Chang; Xiaojun Huang; Xuyu Zhou; Hounan Wu; Kunshan Zhang; Qing Ge
Journal:  Cell Mol Immunol       Date:  2019-06-06       Impact factor: 11.530

Review 4.  Liver fibrosis in biliary atresia.

Authors:  Wen-Jun Shen; Gong Chen; Min Wang; Shan Zheng
Journal:  World J Pediatr       Date:  2018-11-21       Impact factor: 2.764

Review 5.  Recent advances in the pathogenesis and management of biliary atresia.

Authors:  Jessica A Zagory; Marie V Nguyen; Kasper S Wang
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

6.  Low doses of CMV induce autoimmune-mediated and inflammatory responses in bile duct epithelia of regulatory T cell-depleted neonatal mice.

Authors:  Jie Wen; Yongtao Xiao; Jun Wang; Weihua Pan; Ying Zhou; Xiaoling Zhang; Wenbin Guan; Yingwei Chen; Kejun Zhou; Yang Wang; Bisheng Shi; Xiaohui Zhou; Zhenghong Yuan; Wei Cai
Journal:  Lab Invest       Date:  2014-12-22       Impact factor: 5.662

Review 7.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 8.  Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes.

Authors:  Swati Antala; Sarah A Taylor
Journal:  Clin Liver Dis       Date:  2022-06-25       Impact factor: 6.265

9.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

10.  A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia.

Authors:  Cara L Mack; Cathie Spino; Estella M Alonso; Jorge A Bezerra; Jeffrey Moore; Catherine Goodhue; Vicky L Ng; Saul J Karpen; Veena Venkat; Kathleen M Loomes; Kasper Wang; Averell H Sherker; John C Magee; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-04       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.